- Let's make a deal May 6
There's been a high-stakes reshuffling of the deck in the global pharmaceutical industry, and the latest company to show its hand is Germany's Bayer, which said Tuesday morning that it's purchasing Merck's consumer care unit for $14.2 billion. That means the company that pioneered aspirin — and now also makes Alka-Seltzer, Aleve, and Flintstones vitamins, among other brands — will own Claratin, Afrin, Coppertone, and Dr. Scholl's foot products. But the bigger prize for Bayer, assuming the deal goes through, is that it will be the No. 2 consumer drugmaker in the world, after Johnson & Johnson.- -
THE WEEK'S AUDIOPHILE PODCASTS: LISTEN SMARTER
- The 10 best networking tips for people who hate networking
- What would a U.S.-Russia war look like?
- Why the West should let Russia have eastern Ukraine
- 7 grammar rules you really should pay attention to
- Why you should stop believing in evolution
- Your literary playlist: A guide to the music of Haruki Murakami
- 11 scientific studies that will restore your faith in humanity
- 9 Harvard dropouts who became fabulously successful
- Why baseball is America's most dangerous spectator sport
- What would a U.S.-China war look like?
Subscribe to the Week